COUGHLIN TIMOTHY

ATYR

COUGHLIN TIMOTHY serves as Director at aTyr Pharma, Inc. (ATYR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$87.5K

Total Sells

1 trades

$32.8K

Net Position

Net Buyer

$54.7K

Companies Traded

ATYR, FATE

Active Period

Jun 2022 – May 2024

2 total trades

Most Recent

Buy ATYR

May 30, 2024 · $87.5K

COUGHLIN TIMOTHY's Insider Trading at aTyr Pharma, Inc. (ATYR)

Buys

1 · $87.5K

Sells

0 · $0.00

Total Shares Bought

50,000

Total Shares Sold

ATYR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 30, 2024	Buy	50,000	$1.75	$87.5K	0

COUGHLIN TIMOTHY's Insider Trading at Fate Therapeutics, Inc. (FATE)

Buys

0 · $0.00

Sells

1 · $32.8K

Total Shares Bought

Total Shares Sold

1,439

FATE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 6, 2022	Sell	1,439	$22.81	$32.8K	57,632

Related Insiders

Jill Marie Broadfoot

officer: Chief Financial Officer

ATYRSell · Feb 4, 2026

DENYES NANCY

officer: General Counsel

ATYRSell · Feb 4, 2026

Sanjay Shukla

President and CEO

ATYRSell · Feb 4, 2026

TAHL CINDY

See Remarks

FATESell · Jan 12, 2026

Bahram Valamehr

President and CEO

FATESell · Jan 12, 2026

SCHIMMEL PAUL

Director

ATYRBuy · Oct 8, 2025

Explore More Insider Trading Data

ATYR Insider Trading Activity

View all insider trades at aTyr Pharma, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity